Lexeo Therapeutics Inc. LXEO
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Lexeo Therapeutics Inc. is a biotechnology company that focuses on the development and commercialization of innovative genetic therapies for complex diseases. Established with a mission to transform lives through groundbreaking advancements, Lexeo Therapeutics is primarily engaged in addressing genetic disorders that h…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees59
TickerLXEO
Statistics
Market Cap$366.0M
Revenue (TTM)—
Net Income-$100.0M
Net Margin—
EPS$-1.86
P/E-2.36
P/S—
P/B1.40
EV/EBITDA-1.48
ROE-54.8%
Dividend Yield—
Price$4.94
Data: Twelve Data · Revenue = mcap / P/S